iTeos Therapeutics CEO Michel Detheux's 2020 pay jumps 964% to $17M
iTeos Therapeutics reports 2020 executive compensation
By ExecPay News
Published: May 5, 2021
iTeos Therapeutics reported fiscal year 2020 executive compensation information on May 5, 2021.
In 2020, three executives at iTeos Therapeutics received on average a compensation package of $6.7M, a 454% increase compared to previous year.
Michel Detheux, Chief Executive Officer, received $17M in total, which increased by 964% compared to 2019. 95% of Detheux's compensation, or $16M, was in option awards. Detheux also received $121K in bonus, $243K in non-equity incentive plan, $463K in salary, as well as $7.5K in other compensation.
Matthew Gall, Chief Financial Officer, received a compensation package of $1.9M. 76% of the compensation package, or $1.4M, was in option awards.
Joanne Jenkins Lager, Chief Medical Officer, earned $1.3M in 2020, a 57% increase compared to previous year.